Researchers identify a protein that conveys “superpowers” onto prostate cancer cells, causing them to spread aggressively.
Immunotherapy could help a segment of patients with metastatic prostate cancer, a study found.
A novel formulation of abiraterone acetate will dramatically improve the quality of life for men suffering from prostate cancer.
Recovery from COVID-19 looks more promising because of a drug approved in 1958: By Mark Moyad, MD, MPH
View retreat presentations and materials here
To access empowering, decision-making information, join Prostate Cancer Connections; learn more and register for webinar series beginning June 30